NEW Dividend Portfolio Tracker (DRIPTracker) is Now Live!
Add your stocks and see every dividend they pay you — dates, amounts, and reinvested shares.
Start Free »

EXLS | NASDAQ

$36.79 -$0.08 | -0.22%
TREND SIGNAL:Signal available — unlock to view |2026-10-09

Company Overview:

Market Cap: $5.58B
Trailing PE: 23.1x
FWD PE *: 15.4x
Payout Ratio (TTM): —
52-Week Range: $24.85 - $43.88

* Forward PE is based on street estimates.

10 Year EXLS Performance Metrics:

Total Return (with DRIP): 270.9% (14.00% CAGR)
Total Return (no DRIP): 270.9% (14.00% CAGR)
Share Price: 270.9% (14.00% CAGR)
Yield on Cost (with DRIP): —
Total Invested: $10,000
Total Value (with DRIP): $37,087
Total Return $ (with DRIP): $27,087
EXLS Total Return
1M 3M 6M YTD 1Y 3Y 5Y 10Y
EXLS Price Chart
1M 3M 6M YTD 1Y 3Y 5Y 10Y All

Unlock All Reports & Research Dividend Stocks like a BOSS!

Get 3 Months Free with Annual Plan
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
Combined 55% Lifetime Discount
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
Combined 55% Lifetime Discount
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
Combined 55% Lifetime Discount

EXLS Financials: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:

EXLS - Revenue
EXLS Revenue CAGR:1Y: 15.61%2Y: 15.17%5Y: 16.68%10Y: 13.31%
EXLS - Earnings Per Share (EPS)
EXLS EPS CAGR:1Y: 5.00%2Y: 22.47%5Y: 21.29%10Y: 16.15%
EXLS - Net Income
🔓 See the full chart40% off right now · 7-day free trial
EXLS Net Income CAGR:1Y: -2.33%2Y: 18.65%5Y: 18.15%10Y: 14.70%
EXLS - EBITDA
🔓 See the full chart40% off right now · 7-day free trial
EXLS EBITDA CAGR:1Y: 0.55%2Y: 15.31%5Y: 12.03%10Y: 12.47%
EXLS - Free Cash Flow
🔓 See the full chart40% off right now · 7-day free trial
EXLS Free Cash Flow CAGR:1Y: -22.71%2Y: 8.06%5Y: 18.42%10Y: 9.02%
EXLS - Free Cash Flow / Share
🔓 See the full chart40% off right now · 7-day free trial
EXLS Free Cash Flow / Share CAGR:1Y: -17.46%2Y: 11.63%5Y: 21.29%10Y: 10.37%
EXLS - Operating Income
🔓 See the full chart40% off right now · 7-day free trial
EXLS Operating Income CAGR:1Y: 7.59%2Y: 19.19%5Y: 19.49%10Y: 18.32%
EXLS - Gross Profit
🔓 See the full chart40% off right now · 7-day free trial
EXLS Gross Profit CAGR:1Y: 16.36%2Y: 16.58%5Y: 16.71%10Y: 14.48%
EXLS - Shares Outstanding
🔓 See the full chart40% off right now · 7-day free trial
EXLS Shares Outstanding CAGR:1Y: -6.92%2Y: -3.45%5Y: -2.45%10Y: -1.30%
EXLS - Share Buybacks
🔓 See the full chart40% off right now · 7-day free trial
EXLS Share Buybacks CAGR:1Y: -50.53%2Y: 56.48%5Y: -6.21%10Y: 21.89%
EXLS - Stock-Based Comp
🔓 See the full chart40% off right now · 7-day free trial
EXLS Stock-Based Comp CAGR:1Y: 50.26%2Y: 16.67%5Y: 19.59%10Y: 18.66%
EXLS - Expenses
🔓 See the full chart40% off right now · 7-day free trial
EXLS Expenses CAGR:1Y: 0.56%2Y: 9.66%5Y: 14.97%10Y: 8.50%
EXLS - Revenue vs Net Income
🔓 See the full chart40% off right now · 7-day free trial
EXLS - EPS vs FCF / Share
🔓 See the full chart40% off right now · 7-day free trial
EXLS - EPS vs PE Ratio
🔓 See the full chart40% off right now · 7-day free trial
EXLS - FCF vs FCF / Share
🔓 See the full chart40% off right now · 7-day free trial
EXLS - FCF vs Stock Based Comp
🔓 See the full chart40% off right now · 7-day free trial
EXLS - Cash & Debt
🔓 See the full chart40% off right now · 7-day free trial
EXLS - Revenue by Segment
🔓 See the full chart40% off right now · 7-day free trial
EXLS Revenue CAGR:1Y: 15.61%2Y: 15.17%5Y: 16.68%10Y: 13.31%
EXLS - Revenue by Region
🔓 See the full chart40% off right now · 7-day free trial
EXLS Revenue CAGR:1Y: 15.61%2Y: 15.17%5Y: 16.68%10Y: 13.31%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

EXLS - REVENUE: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
EXLS Actual Revenue CAGR:1Y: 15.61%2Y: 15.17%5Y: 16.68%10Y: 13.31%
EXLS - EPS: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
EXLS Actual EPS CAGR:1Y: 5.00%2Y: 22.47%5Y: 21.29%10Y: 16.15%
EXLS - NET INCOME: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
EXLS Actual Net Income CAGR:1Y: -2.33%2Y: 18.65%5Y: 18.15%10Y: 14.70%
EXLS - EBITDA: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
EXLS Actual EBITDA CAGR:1Y: 0.55%2Y: 15.31%5Y: 12.03%10Y: 12.47%

Ratios, Profit Margins & Return on Capital:

EXLS - Net Profit Margin
🔓 See the full chart40% off right now · 7-day free trial
EXLS Net Profit Margin CAGR:1Y: -15.50%2Y: 3.04%5Y: 1.26%10Y: 1.22%
EXLS - Gross Profit Margin
🔓 See the full chart40% off right now · 7-day free trial
EXLS Gross Profit Margin CAGR:1Y: 0.64%2Y: 1.22%5Y: 0.03%10Y: 1.03%
EXLS - Price to Earnings
🔓 See the full chart40% off right now · 7-day free trial
EXLS Price to Earnings CAGR:1Y: -42.35%2Y: -25.47%5Y: -13.94%10Y: -5.67%
EXLS - Price To Sales Ratio
🔓 See the full chart40% off right now · 7-day free trial
EXLS Price To Sales Ratio CAGR:1Y: -52.17%2Y: -23.48%5Y: -12.97%10Y: -4.59%
EXLS - Return on Capital Employed
🔓 See the full chart40% off right now · 7-day free trial
EXLS Return on Capital Employed CAGR:1Y: 47.97%2Y: 28.67%5Y: 17.56%10Y: 10.90%
EXLS - Return on Invested Capital
🔓 See the full chart40% off right now · 7-day free trial
EXLS Return on Invested Capital CAGR:1Y: 7.04%2Y: 13.49%5Y: 11.19%10Y: 8.57%

Compare stocks side-by-side

Projected Future Returns & Dividends for EXLS

Based on past 10-year performance, here are EXLS growth metrics:

Share price CAGR of +13.96%
Dividend CAGR of +0%

Using EXLS CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

EXLS (DRIP)EXLS - No DRIP
Current Price$36.79$36.79
Start Shares271.81271.81
Start Value$10,000$10,000
  
After 10 years:
Final Share Count271.81271.81
Dividends Payment$0.00$0.00
Annual Dividends$0$0
Yield on cost0.00%0.00%
Share Price$36.79$36.79
Total Dividends$0$0
Final Value$10,000$10,000

Estimated Future Value + Dividends - EXLS

NOTE: Above numbers are our estimate based on EXLS's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Get 3 Months Free with Annual Plan
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
Combined 55% Lifetime Discount
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
Combined 55% Lifetime Discount
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
Combined 55% Lifetime Discount

Company Info

ExlService Holdings, Inc. (EXLS) had its IPO on 2006-10-20, and is traded on NASDAQ stock exchange.

ExlService Holdings, Inc. functions as a global provider of data analytics, digital operational solutions, and comprehensive services, operating across the United States and internationally. The company organizes its operations into distinct segments: Insurance, Healthcare, Analytics, and Emerging Business. For the insurance sector, EXL delivers a suite of digital transformation and analytics-driven services. These offerings span a wide array of functions, including streamlined claims processing, administration of premiums and benefits, agency oversight, account reconciliation, policy research, underwriting assistance, new client acquisition, policy servicing, premium audits, various surveys (including commercial and residential), invoicing and collections, and enhanced customer support. These services are powered by cutting-edge digital technologies, artificial intelligence, machine learning, and sophisticated automation. Furthermore, EXL facilitates digital customer acquisition through a Software-as-a-Service (SaaS) model via its LifePRO and LISS platforms, and also provides subrogation services, including its comprehensive Subrosource software platform. In the healthcare domain, EXL presents CareRadius, an integrated care management system. It delivers diverse healthcare services such as care management, utilization review, disease management, payment accuracy, revenue enhancement, and customer interaction strategies for healthcare payers, service providers, pharmacy benefit management companies, and life sciences entities. Beyond these industry-specific services, EXL specializes in advanced predictive and prescriptive analytical capabilities. These are applied to critical areas like customer acquisition and lifecycle navigation, risk assessment and pricing, optimizing operational efficiency, oversight of credit and operational risks, ensuring payment accuracy and care coordination, and comprehensive data governance. Established in 1999, ExlService Holdings, Inc. maintains its corporate headquarters in New York, New York.

EXLS website: https://www.exlservice.com


Get Full Access to All Reports with DRIPCalc PRO

Get 3 Months Free with Annual Plan
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
Combined 55% Lifetime Discount
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
Combined 55% Lifetime Discount
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
Combined 55% Lifetime Discount
Loading signals…

DCF Model — EXLS

Value from:
Pay up to today
—
vs current price $36.79
—
Cash flow & implied price by year

FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.

EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.

Free cash flow today
—
grows for the next years
Then mature
—
every future dollar counted back to today
Pile of today-dollars
—
÷ shares
Implied price path
YearFCFImplied price
Sensitivity — fair value: growth ↓ × target return →